MAIA Biotechnology, Inc. Balance Sheet
MAIA|3 years of annual SEC 10-K data (FY2022-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$10M
FY2024
Cash
$0
Cash and equivalents
Total Debt
N/A
FY2024
Shareholder Equity
$4M
FY2024
MAIA Biotechnology, Inc. had $10M in total assets and $4M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Cash & Equivalents | $0 | $0 | $0 |
| Current Assets | $10.2M | $7.6M | $11.8M |
| Total Assets | $10.2M | $7.6M | $12.0M |
| Current Liabilities | $3.8M | $4.9M | $3.3M |
| Shareholders' Equity | $3.6M | $8.5M | $9.2M |